Join
Live feed
·
PRReleasevia Quantisnow
BioHarvest Sciences Inc. logo

BioHarvest Advances Proprietary Olive Cell Asset to Commercial Readiness, Opening New CDMO Licensing Opportunity

ByQuantisnow·Wall Street's wire, on your screen.
BHST· BioHarvest Sciences Inc.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BHST (BioHarvest Sciences Inc.) and more on Quantisnow.